Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Phase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with NRAS-Mutant MelanomaClin. Cancer Res 2022 Mar 16;[EPub Ahead of Print], M Schuler, L Zimmer, KB Kim, JA Sosman, PA Ascierto, MA Postow, F De Vos, CML van Herpen, MS Carlino, DB Johnson, C Berking, MB Reddy, AS Harney, JD Berlin, RN Amaria
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.